Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin Induction and Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
NCT04834206Phase 2Completed
- Sponsor
- Cancer Center of Guangzhou Medical University
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of nedaplatin in nasopharyngeal carcinoma (NPC), sponsored by Cancer Center of Guangzhou Medical University. Started May 2021; status: completed.
02
Drugs
nedaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04834206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04834206.